Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001208786 | SCV001380193 | benign | Norman-Roberts syndrome; Familial temporal lobe epilepsy 7 | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Ce |
RCV002512145 | SCV002821832 | likely benign | not provided | 2022-10-01 | criteria provided, single submitter | clinical testing | RELN: BP4, BS2 |
Ambry Genetics | RCV002561699 | SCV003756220 | uncertain significance | Inborn genetic diseases | 2022-02-02 | criteria provided, single submitter | clinical testing | The c.7268G>A (p.R2423H) alteration is located in exon 46 (coding exon 46) of the RELN gene. This alteration results from a G to A substitution at nucleotide position 7268, causing the arginine (R) at amino acid position 2423 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |